Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA recruitment status notice 'No longer looking for participants' was added, indicating the study is not enrolling. New help and navigation items—'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'—were added, and the 'Intervention / Treatment' heading was reformatted to 'Intervention/Treatment' while the old 'Revision: v3.5.5' note was removed in favor of 'Revision: v3.6.0'.SummaryDifference0.4%

- Check19 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, signaling a minor update to the study record display.SummaryDifference0.1%

- Check40 days agoChange DetectedThe revision label at the bottom of the page changes from Revision: v3.5.3 to Revision: v3.5.4, indicating a minor update to the page’s version history rather than updates to study content.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now shows an updated revision label (v3.5.3 instead of v3.5.2), indicating a minor site/package update rather than a change to the underlying study information.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.5.2 replaces v3.5.0.SummaryDifference0.1%

- Check98 days agoChange DetectedVersion history updated with new entries for 2026-03-17, 2026-03, 2026-02-25, 2026-02 and Revision: v3.5.0. Older entries such as 2025-03-19, 2026-09, 2025-03-17, 2025-03 and Revision: v3.4.3 were removed.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.